ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Cardiopulmonary Autotransfusion System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-10R2695
Home | Market Reports | Health| Medical Facilities & Services
Global Cardiopulmonary Autotransfusion System Market Insights Forecast to 2026
BUY CHAPTERS

Cardiopulmonary Autotransfusion System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-10R2695
Report
March 2024
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Haemonetics
Medtronic Inc
LivaNova
Fresenius Kabi
Terumo
Wandong Health Sources

Cardiopulmonary Autotransfusion System - Market Size

The global market for Cardiopulmonary Autotransfusion System was estimated to be worth US$ 553 million in 2023 and is forecast to a readjusted size of US$ 654.2 million by 2030 with a CAGR of 2.4% during the forecast period 2024-2030

Cardiopulmonary Autotransfusion System - Market

Cardiopulmonary Autotransfusion System - Market

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cardiopulmonary Autotransfusion System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cardiopulmonary Autotransfusion System by region & country, by Type, and by Application.
The Cardiopulmonary Autotransfusion System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiopulmonary Autotransfusion System.
Market Segmentation

Scope of Cardiopulmonary Autotransfusion System - Market Report

Report Metric Details
Report Name Cardiopulmonary Autotransfusion System - Market
Forecasted market size in 2030 US$ 654.2 million
CAGR 2.4%
Forecasted years 2024 - 2030
Segment by Type:
  • Unwashed ATS
  • Washed ATS
Segment by Application
  • Heart Surgery
  • Great Organ Transplant Surgery
  • Other Surgery
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo, Wandong Health Sources
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Cardiopulmonary Autotransfusion System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Cardiopulmonary Autotransfusion System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Cardiopulmonary Autotransfusion System in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Cardiopulmonary Autotransfusion System - Market size in 2030?

Ans: The Cardiopulmonary Autotransfusion System - Market size in 2030 will be US$ 654.2 million.

What is the market share of major companies in Cardiopulmonary Autotransfusion System - Market?

Ans: The top 3 players occupy about 70% shares of the global market.

What is the Cardiopulmonary Autotransfusion System - Market share by type?

Ans: Washed ATS is the main type, with a share about 90%.

What is the Cardiopulmonary Autotransfusion System - Market share by application?

Ans: Heart Surgery is the main application, which holds a share about 35%.

Who are the main players in the Cardiopulmonary Autotransfusion System - Market report?

Ans: The main players in the Cardiopulmonary Autotransfusion System - Market are Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo, Wandong Health Sources

What are the Application segmentation covered in the Cardiopulmonary Autotransfusion System - Market report?

Ans: The Applications covered in the Cardiopulmonary Autotransfusion System - Market report are Heart Surgery, Great Organ Transplant Surgery, Other Surgery

What are the Type segmentation covered in the Cardiopulmonary Autotransfusion System - Market report?

Ans: The Types covered in the Cardiopulmonary Autotransfusion System - Market report are Unwashed ATS, Washed ATS

1 Market Overview
1.1 Cardiopulmonary Autotransfusion System Product Introduction
1.2 Global Cardiopulmonary Autotransfusion System Market Size Forecast
1.2.1 Global Cardiopulmonary Autotransfusion System Sales Value (2019-2030)
1.2.2 Global Cardiopulmonary Autotransfusion System Sales Volume (2019-2030)
1.2.3 Global Cardiopulmonary Autotransfusion System Sales Price (2019-2030)
1.3 Cardiopulmonary Autotransfusion System Market Trends & Drivers
1.3.1 Cardiopulmonary Autotransfusion System Industry Trends
1.3.2 Cardiopulmonary Autotransfusion System Market Drivers & Opportunity
1.3.3 Cardiopulmonary Autotransfusion System Market Challenges
1.3.4 Cardiopulmonary Autotransfusion System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cardiopulmonary Autotransfusion System Players Revenue Ranking (2023)
2.2 Global Cardiopulmonary Autotransfusion System Revenue by Company (2019-2024)
2.3 Global Cardiopulmonary Autotransfusion System Players Sales Volume Ranking (2023)
2.4 Global Cardiopulmonary Autotransfusion System Sales Volume by Company Players (2019-2024)
2.5 Global Cardiopulmonary Autotransfusion System Average Price by Company (2019-2024)
2.6 Key Manufacturers Cardiopulmonary Autotransfusion System Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Cardiopulmonary Autotransfusion System Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Cardiopulmonary Autotransfusion System
2.9 Cardiopulmonary Autotransfusion System Market Competitive Analysis
2.9.1 Cardiopulmonary Autotransfusion System Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Cardiopulmonary Autotransfusion System Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiopulmonary Autotransfusion System as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Unwashed ATS
3.1.2 Washed ATS
3.2 Global Cardiopulmonary Autotransfusion System Sales Value by Type
3.2.1 Global Cardiopulmonary Autotransfusion System Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cardiopulmonary Autotransfusion System Sales Value, by Type (2019-2030)
3.2.3 Global Cardiopulmonary Autotransfusion System Sales Value, by Type (%) (2019-2030)
3.3 Global Cardiopulmonary Autotransfusion System Sales Volume by Type
3.3.1 Global Cardiopulmonary Autotransfusion System Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Cardiopulmonary Autotransfusion System Sales Volume, by Type (2019-2030)
3.3.3 Global Cardiopulmonary Autotransfusion System Sales Volume, by Type (%) (2019-2030)
3.4 Global Cardiopulmonary Autotransfusion System Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Heart Surgery
4.1.2 Great Organ Transplant Surgery
4.1.3 Other Surgery
4.2 Global Cardiopulmonary Autotransfusion System Sales Value by Application
4.2.1 Global Cardiopulmonary Autotransfusion System Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cardiopulmonary Autotransfusion System Sales Value, by Application (2019-2030)
4.2.3 Global Cardiopulmonary Autotransfusion System Sales Value, by Application (%) (2019-2030)
4.3 Global Cardiopulmonary Autotransfusion System Sales Volume by Application
4.3.1 Global Cardiopulmonary Autotransfusion System Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Cardiopulmonary Autotransfusion System Sales Volume, by Application (2019-2030)
4.3.3 Global Cardiopulmonary Autotransfusion System Sales Volume, by Application (%) (2019-2030)
4.4 Global Cardiopulmonary Autotransfusion System Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Cardiopulmonary Autotransfusion System Sales Value by Region
5.1.1 Global Cardiopulmonary Autotransfusion System Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cardiopulmonary Autotransfusion System Sales Value by Region (2019-2024)
5.1.3 Global Cardiopulmonary Autotransfusion System Sales Value by Region (2025-2030)
5.1.4 Global Cardiopulmonary Autotransfusion System Sales Value by Region (%), (2019-2030)
5.2 Global Cardiopulmonary Autotransfusion System Sales Volume by Region
5.2.1 Global Cardiopulmonary Autotransfusion System Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Cardiopulmonary Autotransfusion System Sales Volume by Region (2019-2024)
5.2.3 Global Cardiopulmonary Autotransfusion System Sales Volume by Region (2025-2030)
5.2.4 Global Cardiopulmonary Autotransfusion System Sales Volume by Region (%), (2019-2030)
5.3 Global Cardiopulmonary Autotransfusion System Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Cardiopulmonary Autotransfusion System Sales Value, 2019-2030
5.4.2 North America Cardiopulmonary Autotransfusion System Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Cardiopulmonary Autotransfusion System Sales Value, 2019-2030
5.5.2 Europe Cardiopulmonary Autotransfusion System Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Cardiopulmonary Autotransfusion System Sales Value, 2019-2030
5.6.2 Asia Pacific Cardiopulmonary Autotransfusion System Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Cardiopulmonary Autotransfusion System Sales Value, 2019-2030
5.7.2 South America Cardiopulmonary Autotransfusion System Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Cardiopulmonary Autotransfusion System Sales Value, 2019-2030
5.8.2 Middle East & Africa Cardiopulmonary Autotransfusion System Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cardiopulmonary Autotransfusion System Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cardiopulmonary Autotransfusion System Sales Value
6.2.1 Key Countries/Regions Cardiopulmonary Autotransfusion System Sales Value, 2019-2030
6.2.2 Key Countries/Regions Cardiopulmonary Autotransfusion System Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Cardiopulmonary Autotransfusion System Sales Value, 2019-2030
6.3.2 United States Cardiopulmonary Autotransfusion System Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cardiopulmonary Autotransfusion System Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cardiopulmonary Autotransfusion System Sales Value, 2019-2030
6.4.2 Europe Cardiopulmonary Autotransfusion System Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cardiopulmonary Autotransfusion System Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cardiopulmonary Autotransfusion System Sales Value, 2019-2030
6.5.2 China Cardiopulmonary Autotransfusion System Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cardiopulmonary Autotransfusion System Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cardiopulmonary Autotransfusion System Sales Value, 2019-2030
6.6.2 Japan Cardiopulmonary Autotransfusion System Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cardiopulmonary Autotransfusion System Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cardiopulmonary Autotransfusion System Sales Value, 2019-2030
6.7.2 South Korea Cardiopulmonary Autotransfusion System Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cardiopulmonary Autotransfusion System Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cardiopulmonary Autotransfusion System Sales Value, 2019-2030
6.8.2 Southeast Asia Cardiopulmonary Autotransfusion System Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cardiopulmonary Autotransfusion System Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cardiopulmonary Autotransfusion System Sales Value, 2019-2030
6.9.2 India Cardiopulmonary Autotransfusion System Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cardiopulmonary Autotransfusion System Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Haemonetics
7.1.1 Haemonetics Company Information
7.1.2 Haemonetics Introduction and Business Overview
7.1.3 Haemonetics Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Haemonetics Cardiopulmonary Autotransfusion System Product Offerings
7.1.5 Haemonetics Recent Development
7.2 Medtronic
7.2.1 Medtronic Company Information
7.2.2 Medtronic Introduction and Business Overview
7.2.3 Medtronic Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Medtronic Cardiopulmonary Autotransfusion System Product Offerings
7.2.5 Medtronic Recent Development
7.3 LivaNova
7.3.1 LivaNova Company Information
7.3.2 LivaNova Introduction and Business Overview
7.3.3 LivaNova Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2019-2024)
7.3.4 LivaNova Cardiopulmonary Autotransfusion System Product Offerings
7.3.5 LivaNova Recent Development
7.4 Fresenius Kabi
7.4.1 Fresenius Kabi Company Information
7.4.2 Fresenius Kabi Introduction and Business Overview
7.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Fresenius Kabi Cardiopulmonary Autotransfusion System Product Offerings
7.4.5 Fresenius Kabi Recent Development
7.5 Terumo
7.5.1 Terumo Company Information
7.5.2 Terumo Introduction and Business Overview
7.5.3 Terumo Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Terumo Cardiopulmonary Autotransfusion System Product Offerings
7.5.5 Terumo Recent Development
7.6 Wandong Health Sources
7.6.1 Wandong Health Sources Company Information
7.6.2 Wandong Health Sources Introduction and Business Overview
7.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Wandong Health Sources Cardiopulmonary Autotransfusion System Product Offerings
7.6.5 Wandong Health Sources Recent Development
8 Industry Chain Analysis
8.1 Cardiopulmonary Autotransfusion System Industrial Chain
8.2 Cardiopulmonary Autotransfusion System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cardiopulmonary Autotransfusion System Sales Model
8.5.2 Sales Channel
8.5.3 Cardiopulmonary Autotransfusion System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Haemonetics
Medtronic Inc
LivaNova
Fresenius Kabi
Terumo
Wandong Health Sources
List of Tables
    Table 1. Cardiopulmonary Autotransfusion System Market Trends
    Table 2. Cardiopulmonary Autotransfusion System Market Drivers & Opportunity
    Table 3. Cardiopulmonary Autotransfusion System Market Challenges
    Table 4. Cardiopulmonary Autotransfusion System Market Restraints
    Table 5. Global Cardiopulmonary Autotransfusion System Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Company (2019-2024)
    Table 7. Global Cardiopulmonary Autotransfusion System Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Cardiopulmonary Autotransfusion System Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Cardiopulmonary Autotransfusion System Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Cardiopulmonary Autotransfusion System Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Cardiopulmonary Autotransfusion System Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Cardiopulmonary Autotransfusion System
    Table 13. Global Cardiopulmonary Autotransfusion System Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiopulmonary Autotransfusion System as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Cardiopulmonary Autotransfusion System Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Cardiopulmonary Autotransfusion System Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Cardiopulmonary Autotransfusion System Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Cardiopulmonary Autotransfusion System Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Cardiopulmonary Autotransfusion System Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Cardiopulmonary Autotransfusion System Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Cardiopulmonary Autotransfusion System Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Cardiopulmonary Autotransfusion System Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Cardiopulmonary Autotransfusion System Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Cardiopulmonary Autotransfusion System Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Cardiopulmonary Autotransfusion System Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Cardiopulmonary Autotransfusion System Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Cardiopulmonary Autotransfusion System Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Cardiopulmonary Autotransfusion System Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Cardiopulmonary Autotransfusion System Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Cardiopulmonary Autotransfusion System Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Cardiopulmonary Autotransfusion System Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Cardiopulmonary Autotransfusion System Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Cardiopulmonary Autotransfusion System Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Cardiopulmonary Autotransfusion System Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Cardiopulmonary Autotransfusion System Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Cardiopulmonary Autotransfusion System Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Cardiopulmonary Autotransfusion System Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Cardiopulmonary Autotransfusion System Sales Value by Region (2019-2024) & (%)
    Table 44. Global Cardiopulmonary Autotransfusion System Sales Value by Region (2025-2030) & (%)
    Table 45. Global Cardiopulmonary Autotransfusion System Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Cardiopulmonary Autotransfusion System Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Cardiopulmonary Autotransfusion System Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Cardiopulmonary Autotransfusion System Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Cardiopulmonary Autotransfusion System Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Cardiopulmonary Autotransfusion System Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Cardiopulmonary Autotransfusion System Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Cardiopulmonary Autotransfusion System Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Cardiopulmonary Autotransfusion System Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Cardiopulmonary Autotransfusion System Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Cardiopulmonary Autotransfusion System Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Cardiopulmonary Autotransfusion System Sales Volume, (2025-2030) & (K Units)
    Table 57. Haemonetics Company Information
    Table 58. Haemonetics Introduction and Business Overview
    Table 59. Haemonetics Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Haemonetics Cardiopulmonary Autotransfusion System Product Offerings
    Table 61. Haemonetics Recent Development
    Table 62. Medtronic Company Information
    Table 63. Medtronic Introduction and Business Overview
    Table 64. Medtronic Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Medtronic Cardiopulmonary Autotransfusion System Product Offerings
    Table 66. Medtronic Recent Development
    Table 67. LivaNova Company Information
    Table 68. LivaNova Introduction and Business Overview
    Table 69. LivaNova Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. LivaNova Cardiopulmonary Autotransfusion System Product Offerings
    Table 71. LivaNova Recent Development
    Table 72. Fresenius Kabi Company Information
    Table 73. Fresenius Kabi Introduction and Business Overview
    Table 74. Fresenius Kabi Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Fresenius Kabi Cardiopulmonary Autotransfusion System Product Offerings
    Table 76. Fresenius Kabi Recent Development
    Table 77. Terumo Company Information
    Table 78. Terumo Introduction and Business Overview
    Table 79. Terumo Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Terumo Cardiopulmonary Autotransfusion System Product Offerings
    Table 81. Terumo Recent Development
    Table 82. Wandong Health Sources Company Information
    Table 83. Wandong Health Sources Introduction and Business Overview
    Table 84. Wandong Health Sources Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Wandong Health Sources Cardiopulmonary Autotransfusion System Product Offerings
    Table 86. Wandong Health Sources Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Cardiopulmonary Autotransfusion System Downstream Customers
    Table 90. Cardiopulmonary Autotransfusion System Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cardiopulmonary Autotransfusion System Product Picture
    Figure 2. Global Cardiopulmonary Autotransfusion System Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Cardiopulmonary Autotransfusion System Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Cardiopulmonary Autotransfusion System Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Cardiopulmonary Autotransfusion System Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Cardiopulmonary Autotransfusion System Report Years Considered
    Figure 7. Global Cardiopulmonary Autotransfusion System Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Cardiopulmonary Autotransfusion System Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cardiopulmonary Autotransfusion System Revenue in 2023
    Figure 10. Cardiopulmonary Autotransfusion System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Unwashed ATS Picture
    Figure 12. Washed ATS Picture
    Figure 13. Global Cardiopulmonary Autotransfusion System Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Cardiopulmonary Autotransfusion System Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Cardiopulmonary Autotransfusion System Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Cardiopulmonary Autotransfusion System Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Cardiopulmonary Autotransfusion System Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Heart Surgery
    Figure 19. Product Picture of Great Organ Transplant Surgery
    Figure 20. Product Picture of Other Surgery
    Figure 21. Global Cardiopulmonary Autotransfusion System Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Cardiopulmonary Autotransfusion System Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Cardiopulmonary Autotransfusion System Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Cardiopulmonary Autotransfusion System Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Cardiopulmonary Autotransfusion System Price by Application (2019-2030) & (USD/Unit)
    Figure 26. North America Cardiopulmonary Autotransfusion System Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Cardiopulmonary Autotransfusion System Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Cardiopulmonary Autotransfusion System Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Cardiopulmonary Autotransfusion System Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Cardiopulmonary Autotransfusion System Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Cardiopulmonary Autotransfusion System Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Cardiopulmonary Autotransfusion System Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Cardiopulmonary Autotransfusion System Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Cardiopulmonary Autotransfusion System Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Cardiopulmonary Autotransfusion System Sales Volume (%), (2019-2030)
    Figure 38. United States Cardiopulmonary Autotransfusion System Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Cardiopulmonary Autotransfusion System Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Cardiopulmonary Autotransfusion System Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Cardiopulmonary Autotransfusion System Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Cardiopulmonary Autotransfusion System Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Cardiopulmonary Autotransfusion System Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Cardiopulmonary Autotransfusion System Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Cardiopulmonary Autotransfusion System Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Cardiopulmonary Autotransfusion System Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Cardiopulmonary Autotransfusion System Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Cardiopulmonary Autotransfusion System Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Cardiopulmonary Autotransfusion System Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Cardiopulmonary Autotransfusion System Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Cardiopulmonary Autotransfusion System Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Cardiopulmonary Autotransfusion System Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Cardiopulmonary Autotransfusion System Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Cardiopulmonary Autotransfusion System Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Cardiopulmonary Autotransfusion System Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Cardiopulmonary Autotransfusion System Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Cardiopulmonary Autotransfusion System Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Cardiopulmonary Autotransfusion System Sales Value by Application (%), 2023 VS 2030
    Figure 59. Cardiopulmonary Autotransfusion System Industrial Chain
    Figure 60. Cardiopulmonary Autotransfusion System Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global ECG And EEG Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-29U9219
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Deformity Spinal System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20S6127
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Mammography Equipment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-33G9187
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global E-Clinical Solution Software Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Othe-3E434
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions